EPIPHANY TECHNOLOGY ACQUISIT's ticker is EPHY and the CUSIP is 29429X109. A total of 92 filers reported holding EPIPHANY TECHNOLOGY ACQUISIT in Q1 2022. The put-call ratio across all filers is 0.91 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $1,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Hawkeye Capital Management, LLC | 632,138 | $6,208,000 | 3.39% |
| RP Investment Advisors LP | 804,057 | $7,896,000 | 1.11% |
| HGC Investment Management Inc. | 3,430,000 | $33,684,000 | 1.03% |
| Sage Rock Capital Management LP | 359,298 | $3,528,000 | 0.70% |
| Privium Fund Management (UK) Ltd | 51,000 | $501,000 | 0.57% |
| Saba Capital Management, L.P. | 3,804,539 | $37,361,000 | 0.44% |
| CVI Holdings, LLC | 568,882 | $5,586,000 | 0.41% |
| Castle Creek Arbitrage, LLC | 728,652 | $7,155,000 | 0.39% |
| BASSO CAPITAL MANAGEMENT, L.P. | 373,790 | $3,671,000 | 0.38% |
| ARISTEIA CAPITAL, L.L.C. | 2,011,452 | $19,752,000 | 0.35% |